Portfolio returned -6.5% versus benchmark +6.3% as NTA fell to $0.80

On Annolyse's historical baseline this portfolio return is an unprecedented low, sitting well below the four-period range of 1.5%–6.6% and the mean of 3.7%.

NTA per share fell to $0.80 from $1.26 at HY22, a decline of 36.7% that places the unit value below its historical range of $0.94–$1.26. Net assets attributable to shareholders contracted to $161.9m from $242.1m, an unprecedented low against the four-period mean of $220.4m. Investment total return swung to -$9.4m from +$6.3m, dragging NPAT to a loss of $11.6m versus a $3.6m profit in HY22.

The board declared an interim distribution of 1.66cps, down 33.3% from 2.49cps in the prior comparable.

• A -6.5% portfolio return against a +6.3% benchmark means the issue is not just adverse equity markets — Marlin's stock selection also detracted by 12.8pp. The prior comparable already showed a 2.7pp shortfall, so the underperformance is widening rather than mean-reverting.
• Asset base shrinkage compounds the income problem. Net assets fell 33.1% and total assets are an unprecedented low at $163.0m versus a historical mean of $222.8m. A smaller, lower-returning portfolio constrains future fee-bearing capital and the dollar quantum of dividend and interest income — disclosed at roughly $0.3m for the period — that can support distributions.
• The distribution is being paid from capital, not return. Distributions paid in the period totalled 3.70cps while investment income was deeply negative; distribution coverage from current-period earnings sits at 6.9%. Continuing distributions while NAV erodes 36.7% raises a direct sustainability question.

The available second-half shape data is dominated by the FY22 full-year NPAT loss of $60.4m, which itself reflected the same equity-market drawdown, so it does not provide a clean run-rate for HY23.

What the release does support is that the portfolio is now meaningfully smaller and lower-priced than at any point in the four-period historical window, so even a normalised market environment would have to deliver outsized recovery to restore prior NAV per share. The release does not provide a benchmark-relative outlook or any commentary on positioning changes designed to close the 12.8pp gap.

Recorded losses on investments of approximately $9.7m account for the swing from a $6.0m gain in HY22 to a $9.4m loss in HY23; underlying dividend and interest income remained modest. Because portfolio movements are fair-value driven rather than timing-driven, the loss is real and durable in the sense that NAV per share has been reset — there is no working-capital or accrual reversal to look forward to.

Operating cash inflow of $7.5m rose from $5.3m, but for an investment company this primarily reflects dividend, interest and trading flows rather than operational earnings quality, so it should not be read as offsetting the portfolio outcome. The negative effective tax rate of -9.1% is a mechanical consequence of the pre-tax loss and the PIE tax framework rather than a one-off benefit, which is why PBT growth of -354.2% and NPAT growth of -421.4% should both be read through the same lens: the cleaner read is the portfolio's -12.8pp benchmark gap and the unprecedented-low ROE of -7.2%.

This briefing cannot assess prospective portfolio performance, market direction, or the manager's response strategy beyond what is disclosed in the release.